New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
11:52 EDTSTEMEarly research shows promise of stem cells in treating blindness, NY Post says
A clinical trial in mice published by Britain's Medical Research Council and in the science journal "Nature Biotechnology" showed that researchers were able to get blind mice to react to light after stem cell therapy, according to AFP via Fox News. Shares of StemCells (STEM), which is engaged in the research, development, and commercialization of stem cell therapies, moved about 3% higher following the report. Reference Link
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
10:35 EDTSTEMStemCells appoints Ian Massey as President and COO effective March 23
Subscribe for More Information
March 16, 2015
16:23 EDTSTEMStemCells reports Q4 EPS (14c), one estimate (4c)
Reports Q4 revenue $883K vs 45K in Q413. "Total revenue from continuing operations during the fourth quarter of 2014 was $883,000, compared to $45,000 in the same period of 2013. Revenue from continuing operations is primarily from royalties and milestone payments received under various licensing agreements. The increase in 2014 was primarily attributable to a milestone payment of approximately $500,000 received under a licensing agreement with ReNeuron Ltd. and a licensing fee of approximately $400,000 in connection with our divestiture of the SC Proven business entered into with Takara Bio Inc., a publicly traded Japanese company."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use